The IL-23Th17 axis in the immunopathogenesis of psoriasis

Journal of Investigative Dermatology

Volumn 129, Issue 6, 2009, Pages 1339-1350

  Di Cesare, Antonella ^a,b   Di Meglio, Paola ^a   Nestle, Frank O ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 874; CYTOKINE; ETANERCEPT; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PLACEBO; USTEKINUMAB; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ARTHRALGIA; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HEADACHE; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHINOPHARYNGITIS; SKIN DISEASE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; CLINICAL TRIAL; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; CYTOKINES; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-23; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PSORIASIS; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 67349230808     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.59     Document Type: Review

References (152)

1. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S et al. (2000) Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 192:681-94
2. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007a) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942-9
3. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al. (2007b) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639-46
4. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910-4
5. Albanesi C, , Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G (2000) Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 115:81-7
6. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F et al. (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-5
7. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y et al. (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129:969-84
8. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, Liu YJ et al. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 204:1509-17
9. Arican O, Aral M, Sasmaz S, Ciragil P (2005) Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005:273-9
10. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752-9
11. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S et al. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7:929-36
12. Belladonna ML, RenauldJC, Bianchi R, Vacca C, Fallarino F, Orabona C et al. (2002) IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J Immunol 168:5448-54
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-8
14. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345-50
15. Blauvelt A (2008) T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 128: 1064-7
16. Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, Bernard FX et al. (2007) A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150:407-15
17. Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML (1989) Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res 281:24-30
18. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199:731-6
19. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflamma-tory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290:G827-38
20. Brok HP, van Meurs M, Blezer E, Schantz A, Peritt D, Treacy G et al. (2002) Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. J Immunol 169:6554-63
21. Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA et al. (2006) A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis 12:558-65
22. Bush KA, Farmer KM, Walker JS, Kirkham BW (2002) Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum 46:802-5
23. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201-6
24. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273-90
25. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L et al. (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963-70
26. Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203:2557-87
27. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N etal. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-86
28. Chen Z, O'Shea JJ (2008) Regulation of IL-17 production in human lymphocytes. Cytokine 41:71-8
29. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ (2007) Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56:2936-46
30. Cho ML, Ju JH, Kim KW, Moon YM, Lee SY, Min SY et al. (2007) Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett 108:88-96
31. Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH et al. (2003) CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 170:1958-63
32. Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A et al. (2007) Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 13:836-42
33. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F et al. (2008) Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 205:1903-16
34. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-8
35. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M et al. (2008) Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205:1543-50
36. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ et al. (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-8
37. De Panfilis G, Manara GC, Ferrari C, Torresani C, Zucchi A, Devoto RM (1989) Further characterization of the "incipient lesion of chronic stationary type psoriasis vulgaris in exacerbation". The CD4-positive lymphocytes are the prominent cell population infiltrating the dermis. Acta Derm Venereol Suppl 146:26-30
38. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-3
39. Elmaagacli AH, Koldehoff M, Landt O, Beelen DW (2008) Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant 41:821-6
40. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM (2007) Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci USA 104:17034-9
41. Farago B, Magyari L, Safrany E, Csongei V, Jaromi L, Horvatovich K et al. (2008) Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 67:248-50
42. Ferenczi K, Burack L, Pope M, Krueger JG, Austin LM (2000) CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 14:63-78
43. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al. (1996) T cell interleukin-17 induces stromal cells to produce proin-flammatory and hematopoietic cytokines. J Exp Med 183:2593-603
44. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70
45. Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F et al. (2006) Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 12:9-15
46. Goedkoop AY, de Rie MA, Picavet DI, Kraan MC, Dinant HJ, van Kuijk AW et al. (2004) Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis. Arch Dermatol Res 295:465-73
47. Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA et al. (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175:2721-9
48. Gottlieb AB, Cooper KD, McCormick TS, Toichi E, Everitt DE, Frederick B et al. (2007) A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis. Curr Med Res Opin 23:1081-92
49. Haider AS, Cohen J, Fei J, Zaba LC, Cardinale I, Toyoko K et al. (2008a) Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF- regulated genes linked to psoriasis transcriptome. J Invest Dermatol 128:655-66
50. Haider AS, Lowes MA, Suarez-Farinas M, Zaba LC, Cardinale I, Khatcherian A et al. (2008b) Identification of cellular pathways of "type 1", Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 180:1913-20
51. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-32
52. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV et al. (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237:123-30
53. Hong K, Chu A, Lùdvìksson BR, Berg EL, Ehrhardt RO (1999) IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 162:7480-91
54. Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190:624-31
55. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid auto-immunity. J Clin Endocrinol Metab 93:1077-81
56. Hvid H, Teige I, Kvist PH, Svensson L, Kemp K (2008) TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol 20:1097-106
57. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K et al. (2005) Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52:1037-46
58. Illes Z, Safrany E, Peterfalvi A, Magyari L, Farago B, Pozsonyi E et al. (2008) 3′UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 431:36-8
59. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T (2000) Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165:6107-15
60. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-33
61. Kageyama Y, Ichikawa T, Nagafusa T, Torikai E, Shimazu M, Nagano A (2007) Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis. Rheumatol Int 28:137-43
62. Kanda N, Watanabe S (2008) IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur J Immunol 38:1287-96
63. Kastelein RA, Hunter CA, Cua DJ (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25:221-42
64. Kauffman CL, Aria N, Toichi E, McCormick TE, Cooper KD, Gottlieb AB et al. (2004) A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J Invest Dermatol 123:1037-44
65. Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J (2008) Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol 144:200-7
66. Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM et al. (2007) IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204:161-70
67. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128:2625-30
68. Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M et al. (2007) Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 18:15-22
69. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-73
70. Kopp T, Lenz P, Bello-Fernandez C, Kastelein RA, Kupper TS, Stingl G (2003) IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J Immunol 170:5438-44
71. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484-7
72. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345-52
73. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al., CNTO 1275 Psoriasis Study Group (2007) A human interleukin-12/23 monoclonal antibody for the treatment of plaque psoriasis. N Eng J Med 356:580-92
74. Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y et al. (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455-63
75. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-40
76. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-30
77. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV et al. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630-8
78. Leonard JP, Waldburger KE, Schaub RG, Smith T, Hewson AK, Cuzner ML et al. (1997) Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit Rev Immunol 17:545-53
79. Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665-74
80. Lew W, Bowcock AM, Krueger JG (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol 25:295-305
81. Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX (2007) Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 130:490-501
82. Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX (2008) Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol 84:1-8
83. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M et al. (2007) An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179: 7791-9
84. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-9
85. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-8
86. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-11
87. Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607
88. Manel N, Unutmaz D, Littman DR (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9:641-9
89. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-4
90. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351:2069-79
91. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT et al. (2007) Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178:4901-7
92. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S et al. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5:101-4
93. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-57
94. Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301:555
95. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al. (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951-7
96. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R et al. (2008) Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 128:1653-61
97. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173-7
98. Nestle FO, Conrad C (2004) The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis. J Invest Dermatol 123:xiv-xv
99. Nestle FO, Turka LA, Nickoloff BJ (1994) Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 94:202-9
100. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-90
101. Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155:145-58
102. Nunez C, Dema B, Cenit MC, Polanco I, Maluenda C, Arroyo R et al. (2008) IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun 9:289-93
103. O'Garra A, Stockinger B, Veldhoen M (2008) Differentiation of human T(H)-17 cells does require TGF-beta!. Nat Immunol 9:588-90
104. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-25
105. Oxenius A, Karrer U, Zinkernagel RM, Hengartner H (1999) IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 162:965-73
106. Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675-84
107. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699-708
108. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-41
109. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779-90
110. Pirhonen J, Matikainen S, Julkunen I (2002) Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 169:5673-8
111. Piskin G, Sylva-Steenland RMR, Bos JD, Teunissen MBM (2006) In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 176:1908-15
112. Piskin G, Tursen U, Sylva-Steenland RM, Bos JD, Teunissen MB (2004) Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers - IL-12, IL-18 and IL-23. Exp Dermatol 13:764-72
113. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71
114. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D et al. (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180:5167-71
115. Reddy M, Davis C, Wong J, Marsters P, Pendley C, Prabhakar U (2007) Modulation of CLA, IL-12R, CD40L, and IL-2Ra expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275. Cell Immunol 247:1-11
116. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20:353-7
117. Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ et al. (2008) The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67:1451-4
118. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L et al. (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178:2229-40
119. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y et al. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673-82
120. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H et al. (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-9
121. Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleu-kin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11:16-23
122. Shin HC, Benbernou N, Esnault S, Guenounou M (1999) Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 11:257-66
123. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7:937-45
124. t Hart BA, Brok HP, Remarque E, Benson J, Treacy G, Amor S et al. (2005) Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J Immunol 175:4761-8
125. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111:645-9
126. Toichi E, Torres G, McCormick TS, Chang T, Mascelli MA, Kauffman CL et al. (2006) An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 177:4917-26
127. Trinchieri G (1998) Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 16:365-96
128. Vaknin-Dembinsky A, Balashov K, Weiner HL (2006) IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 176:7768-74
129. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated auto-immunity to environmental toxins. Nature 453:106-9
130. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-89
131. Vollmer S, Menssen A, Prinz JC (2001) Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J Invest Dermatol 117:1296-301
132. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E et al. (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9:650-7
133. Wada Y, Lu R, Zhou D, Chu J, Przewloka T, Zhang S et al. (2007) Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. Blood 109:1156-64
134. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821-52
135. Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, Vassileva G et al. (2001) Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol 166:7563-70
136. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-7
137. Wolk K, Kunz S, Asadullah K, Sabat R (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168:5397-402
138. Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17:367-80
139. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309-23
140. Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589-93
141. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-87
142. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M et al. (2008a) IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350-2
143. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS et al. (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358-63
144. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y et al. (2008b) T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and RORgamma. Immunity 28:29-39
145. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25:335-40
146. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310-6
147. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez Farinas M, Fuentes-Duculan J et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-94
148. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129:79-88
149. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51
150. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-74
151. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD et al. (2008) TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236-40
152. Zou J, Presky DH, Wu CY, Gubler U (1997) Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem 272:6073-7